|
|
Volumn 29, Issue 1-2, 1997, Pages 272-273
|
|
Neoral vs Sandimmun: Interim results of a randomized trial of efficacy and safety in preventing acute rejection in new renal transplant recipients
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
STEROID;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
GRAFT SURVIVAL;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY GRAFT REJECTION;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL;
ADMINISTRATION, ORAL;
AZATHIOPRINE;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
STEROIDS;
|
|
EID: 0030985755
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(96)00089-9 Document Type: Conference Paper |
|
Times cited : (44)
|
|
References (0)
|
